Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study to Assess the Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe COPD

ClinicalTrials.gov ID: NCT02343458

Public ClinicalTrials.gov record NCT02343458. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 24, 2026, 12:34 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Chronic Dosing (24 Weeks), Placebo-Controlled, Parallel Group, Multi-Center Study to Assess the Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe COPD, Compared With Placebo

Study identification

NCT ID
NCT02343458
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pearl Therapeutics, Inc.
Industry
Enrollment
1,756 participants

Conditions and interventions

Interventions

  • GFF MDI (PT003) Drug
  • FF MDI (PT005) Drug
  • GP MDI (PT001) Drug
  • Placebo MDI Drug

Drug

Eligibility (public fields only)

Age range
40 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 29, 2015
Primary completion
Aug 30, 2017
Completion
Aug 30, 2017
Last update posted
Feb 19, 2019

2015 – 2017

United States locations

U.S. sites
44
U.S. states
15
U.S. cities
40
Facility City State ZIP Site status
Research Site Andalusia Alabama 36420
Research Site Birmingham Alabama 35209
Research Site Foley Alabama 36535
Research Site Jasper Alabama 35501
Research Site Anaheim California 92801
Research Site Boulder Colorado 80301
Research Site Clearwater Florida 33756
Research Site Clearwater Florida 33765
Research Site Kissimmee Florida 34744
Research Site Miami Florida 33175
Research Site Miami Florida 33186
Research Site Panama City Florida 32405
Research Site Pensacola Florida 32503
Research Site Tamarac Florida 33321
Research Site Tampa Florida 33603
Research Site Winter Park Florida 32789-4681
Research Site Atlanta Georgia 30331
Research Site Blue Ridge Georgia 30513
Research Site North Dartmouth Massachusetts 02747
Research Site Edina Minnesota 55435
Research Site Fridley Minnesota 55432
Research Site Minneapolis Minnesota 55407
Research Site Woodbury Minnesota 55125
Research Site Saint Charles Missouri 63301
Research Site St Louis Missouri 63141
Research Site Gastonia North Carolina 28054
Research Site Winston-Salem North Carolina 27103
Research Site Cincinnati Ohio 45242
Research Site Columbus Ohio 43215
Research Site Columbus Ohio 43231
Research Site Dayton Ohio 45419
Research Site Dayton Ohio 45459
Research Site Dublin Ohio 43016
Research Site Oklahoma City Oklahoma 73103
Research Site Medford Oregon 97504
Research Site Easley South Carolina 29640
Research Site Gaffney South Carolina 29341
Research Site Greenville South Carolina 29615
Research Site Rock Hill South Carolina 29732
Research Site Seneca South Carolina 29678
Research Site Spartanburg South Carolina 29303
Research Site Union South Carolina 29379
Research Site Johnson City Tennessee 37601
Research Site Abingdon Virginia 24210

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 122 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02343458, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 19, 2019 · Synced Jul 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02343458 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →